A detailed history of Laurel Wealth Advisors, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 9,827 shares of DGX stock, worth $1.35 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
9,827
Previous 10,207 3.72%
Holding current value
$1.35 Million
Previous $1.25 Million 22.76%
% of portfolio
0.15%
Previous 0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$123.31 - $157.26 $46,857 - $59,758
-380 Reduced 3.72%
9,827 $1.54 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $29,224 - $33,864
-240 Reduced 2.3%
10,207 $1.25 Million
Q2 2022

Aug 12, 2022

SELL
$127.07 - $145.39 $50,828 - $58,155
-400 Reduced 3.69%
10,447 $1.39 Million
Q1 2022

May 13, 2022

BUY
$129.09 - $164.35 $101,464 - $129,179
786 Added 7.81%
10,847 $1.49 Million
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $46,318 - $57,093
-330 Reduced 3.18%
10,061 $1.74 Million
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $2,791 - $3,318
21 Added 0.2%
10,391 $1.51 Million
Q2 2021

Aug 16, 2021

SELL
$126.66 - $141.48 $12,666 - $14,147
-100 Reduced 0.96%
10,370 $1.37 Million
Q1 2021

May 14, 2021

SELL
$114.63 - $133.34 $34,389 - $40,002
-300 Reduced 2.79%
10,470 $1.34 Million
Q4 2020

Mar 03, 2021

SELL
$112.7 - $128.05 $1,352 - $1,536
-12 Reduced 0.11%
10,770 $1.28 Million
Q3 2020

Nov 13, 2020

BUY
$107.05 - $130.01 $81,143 - $98,547
758 Added 7.56%
10,782 $1.23 Million
Q2 2020

Aug 14, 2020

SELL
$73.34 - $122.61 $3,446 - $5,762
-47 Reduced 0.47%
10,024 $1.14 Million
Q1 2020

May 15, 2020

BUY
$75.14 - $115.68 $756,734 - $1.17 Million
10,071 New
10,071 $809,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Laurel Wealth Advisors, Inc. Portfolio

Follow Laurel Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.